title: NOVEL APPROACHES TO Topical Psoriasis Therapy.
abstract: Topical corticosteroids are the cornerstone of treatment for the majority of psoriasis patients. However, potential side effects of topical corticosteroids (i.e., cutaneous atrophy, telangiectasias, hypothalamic-pituitary axis suppression), coupled with the complex pathophysiology of psoriasis and the individual needs/preferences of psoriasis patients, represent a few of the limitations associated with topical corticosteroid monotherapy. While the combination of some agents with varying mechanisms of action has proven to be an effective strategy for improving efficacy and reducing concomitant drug application, others have displayed less efficacy, harm, and/or reduced cost-effectiveness. The purpose of this article is to review novel topical therapeutic combinations for the management of psoriasis and explore the role compounding pharmacies can have in providing healthcare providers and patients with effective and affordable alternative psoriasis therapies.
authors.forename: Gregory
authors.initials: G
authors.lastname: Koyama
authors.forename: Jenny
authors.initials: J
authors.lastname: Liu
authors.forename: Alyse
authors.initials: A
authors.lastname: Scaffidi
authors.forename: Maryam
authors.initials: M
authors.lastname: Khazraee
authors.forename: Benjamin
authors.initials: B
authors.lastname: Epstein
mesh_terms: D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D002762:Cholecalciferol / Q000031:analogs & derivatives; D004359:Drug Therapy, Combination; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D011565:Psoriasis / Q000188:drug therapy*; D014508:Urea / Q000008:administration & dosage
chemical_list: D000305:Adrenal Cortex Hormones; D002762:Cholecalciferol; D014508:Urea; D008727:Methotrexate